Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Pazdur: I Won't Turn Into A Bureaucrat; My Presence Will Be Felt

Executive Summary

Richard Pazdur, who is moving from being the head of the FDA's Office of Hematology and Oncology Products (OHOP) to the agency's acting director of the newly created Oncology Center of Excellence, established under the White House's National Cancer Moonshot initiative, sat down with reporters on June 29 to explain his new role, but warned don't think he's just going to turn into some sort of a bureaucrat and to anticipate his presence to continue to very much be felt at OHOP.

Advertisement

Related Content

FDA's Pazdur Jumps Over To New 'Moonshot' Role
Unifying On Immunotherapy: Will It Pay Off?
Can 'Moon Shot' Lift FDA Out Of Its Silos?
FDA 'Moon Shot' Center To Expedite Combo Cancer Drugs
Obama/Biden: Science Ready For Cancer 'Moon Shot'

Topics

Advertisement
UsernamePublicRestriction

Register

SC065557

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel